Who owns BELITE BIO INC?
- Ticker: BLTE
- CUSIP Number: 07782b104
Tip: Access positions for across all investors
Analyze quarterly positions in Belite Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Belite Bio stock
Who bought or sold BELITE BIO INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Marshall Wace | 11k | $406k | -34% | Mar 2024 |
|
| Point72 Asset Management | 8.7k | $334k | 13% | Mar 2024 |
|
| Geode Capital Management | 6.7k | $257k | 0% | Mar 2024 |
|
| Morgan Stanley | 6.1k | $234k | 1290% | Mar 2024 |
|
| Jump Financial | 5.2k | $238k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 4.8k | $184k | -72% | Mar 2024 |
|
| Virtus ETF Advisers | 2.0k | $75k | -7% | Mar 2024 |
|
| Bank of America Corporation | 1.7k | $66k | -22% | Mar 2024 |
|
| Jpmorgan Chase & Co | 658.00 | $25k | -95% | Mar 2024 |
|
| GAMMA Investing | 234.00 | $9.0k | 18% | Mar 2024 |
|
| Advisor Group Holdings | 5.00 | $192.000000 | -86% | Mar 2024 |
|
Who sold out of Belite Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Qube Research & Technologies | Sep 2023 | 525.00 | $17k |
| UBS Group | Dec 2023 | 348.00 | $16k |